These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 30442431)

  • 1. Pharmacoeconomic impact of an alternative workflow process for stroke.
    Gilbert BW; Huffman JB; Slechta J; Porter C; Gallagher JM
    Am J Emerg Med; 2019 Feb; 37(2):294-297. PubMed ID: 30442431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Door-to-needle times for tissue plasminogen activator administration and clinical outcomes in acute ischemic stroke before and after a quality improvement initiative.
    Fonarow GC; Zhao X; Smith EE; Saver JL; Reeves MJ; Bhatt DL; Xian Y; Hernandez AF; Peterson ED; Schwamm LH
    JAMA; 2014 Apr 23-30; 311(16):1632-40. PubMed ID: 24756513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of an emergency medicine pharmacist on door to needle alteplase time and patient outcomes in acute ischemic stroke.
    Barbour J; Hushen P; Newman GC; Vidal J
    Am J Emerg Med; 2022 Jan; 51():358-362. PubMed ID: 34823191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hospital variation in thrombolysis times among patients with acute ischemic stroke: the contributions of door-to-imaging time and imaging-to-needle time.
    Sauser K; Levine DA; Nickles AV; Reeves MJ
    JAMA Neurol; 2014 Sep; 71(9):1155-61. PubMed ID: 25023407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Results of a 1-year quality-improvement process to reduce door-to-needle time in acute ischemic stroke with MRI screening.
    Sablot D; Gaillard N; Colas C; Smadja P; Gely C; Dutray A; Bonnec JM; Jurici S; Farouil G; Ferraro-Allou A; Jantac M; Allou T; Pujol C; Olivier N; Laverdure A; Fadat B; Mas J; Dumitrana A; Garcia Y; Touzani H; Perucho P; Moulin T; Richard C; Heroum C; Bouly S; Sagnes-Raffy C; Heve D
    Rev Neurol (Paris); 2017; 173(1-2):47-54. PubMed ID: 28131535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delays in door-to-needle time for acute ischemic stroke in the emergency department: A comprehensive stroke center experience.
    Mowla A; Doyle J; Lail NS; Rajabzadeh-Oghaz H; Deline C; Shirani P; Ching M; Crumlish A; Steck DA; Janicke D; Levy EI; Sawyer RN
    J Neurol Sci; 2017 May; 376():102-105. PubMed ID: 28431590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of Rate-Limiting Steps in the Provision of Thrombolytics for Acute Ischemic Stroke.
    Metts EL; Bailey AM; Weant KA; Justice SB
    J Pharm Pract; 2017 Dec; 30(6):606-611. PubMed ID: 27834297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved door-to-needle times and neurologic outcomes when IV tissue plasminogen activator is administered by emergency physicians with advanced neuroscience training.
    Greenberg K; Maxwell CR; Moore KD; D'Ambrosio M; Liebman K; Veznedaroglu E; Sanfillippo G; Diaz C; Binning MJ
    Am J Emerg Med; 2015 Feb; 33(2):234-7. PubMed ID: 25498530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Bedside Preparation in Reducing "Door-to-Needle" Tissue-Type Plasminogen Activator (Alteplase) Administration Times and Association with Patient Outcomes.
    Lebahn KK; Waybright RA; Ngorsuraches S; Johnson TJ
    S D Med; 2018 Sep; 71(9):416-421. PubMed ID: 30308121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Local Tailoring on Acute Stroke Care in 21 Disparate Emergency Departments: A Prospective Stepped Wedge Type III Hybrid Effectiveness-Implementation Study.
    McKee KE; Knighton AJ; Veale K; Martinez J; McCann C; Anderson JW; Wolfe D; Blackburn R; McKasson M; Bardsley T; Ofori-Atta B; Greene TH; Hoesch R; Püttgen HA; Srivastava R
    Circ Cardiovasc Qual Outcomes; 2024 May; 17(5):e010477. PubMed ID: 38567507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temporal sustainability of guideline based door-to-needle times for intravenous thrombolysis for acute ischemic stroke.
    Raina A; Trivedi M; Kate M; Kumar L; Erat Sreedharan S; Sylaja PN
    J Clin Neurosci; 2020 Apr; 74():164-167. PubMed ID: 32094070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Target Door-to-Needle Time for Tissue Plasminogen Activator Treatment with Magnetic Resonance Imaging Screening Can Be Reduced to 45 min.
    Sablot D; Ion I; Khlifa K; Farouil G; Leibinger F; Gaillard N; Laverdure A; Bensalah ZM; Mas J; Fadat B; Smadja P; Ferraro-Allou A; Bonnec JM; Olivier N; Dutray A; Tardieu M; Dumitrana A; Guibal A; Jurici S; Bertrand JL; Allou T; Arquizan C; Bonafe A
    Cerebrovasc Dis; 2018; 45(5-6):245-251. PubMed ID: 29843148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stop Stroke: A Brief Report on Door-to-Needle Times and Performance After Implementing an Acute Care Coordination Medical Application and Implications to Emergency Medical Services.
    Dickson R; Nedelcut A; Nedelcut MM
    Prehosp Disaster Med; 2017 Jun; 32(3):343-347. PubMed ID: 28219452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regional Intervention of Stroke Care to Increase Thrombolytic Therapy for Acute Ischemic Stroke.
    Damani RH; Anand S; Asgarisabet P; Bissell C; Savitz S; Suarez JI
    Stroke; 2018 Aug; 49(8):2008-2010. PubMed ID: 29991653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patients with Low National Institutes of Health Stroke Scale Scores Have Longer Door-to-Needle Times: Analysis of a Telestroke Network.
    Bhatt A; Lesko A; Lucas L; Kansara A; Baraban E
    J Stroke Cerebrovasc Dis; 2016 Sep; 25(9):2253-8. PubMed ID: 27266620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Door to Needle Time over Telestroke-A Comprehensive Stroke Center Experience.
    Al Kasab S; Harvey JB; Debenham E; Jones DJ; Turner N; Holmstedt CA
    Telemed J E Health; 2018 Feb; 24(2):111-115. PubMed ID: 28753069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors that Influence Door-to-Needle Administration for Acute Stroke Patients in the Emergency Department.
    Davis NW; Bailey M; Buchwald N; Farooqui A; Khanna A
    J Neurosci Nurs; 2021 Jun; 53(3):134-139. PubMed ID: 33883535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of Strategies to Improve Door-to-Needle Times With Tissue-Type Plasminogen Activator in Acute Ischemic Stroke in Clinical Practice: Findings from Target: Stroke.
    Xian Y; Xu H; Lytle B; Blevins J; Peterson ED; Hernandez AF; Smith EE; Saver JL; Messé SR; Paulsen M; Suter RE; Reeves MJ; Jauch EC; Schwamm LH; Fonarow GC
    Circ Cardiovasc Qual Outcomes; 2017 Jan; 10(1):. PubMed ID: 28096207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel Telestroke Program Improves Thrombolysis for Acute Stroke Across 21 Hospitals of an Integrated Healthcare System.
    Nguyen-Huynh MN; Klingman JG; Avins AL; Rao VA; Eaton A; Bhopale S; Kim AC; Morehouse JW; Flint AC;
    Stroke; 2018 Jan; 49(1):133-139. PubMed ID: 29247142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment Delays for Patients With Acute Ischemic Stroke in an Iranian Emergency Department: A Retrospective Chart Review.
    Hassankhani H; Soheili A; Vahdati SS; Mozaffari FA; Fraser JF; Gilani N
    Ann Emerg Med; 2019 Feb; 73(2):118-129. PubMed ID: 30318375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.